Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
156.4 USD | +0.91% | +4.01% | +5.16% |
May. 06 | HC Wainwright Adjusts Balchem Price Target to $170 From $167, Maintains Buy Rating | MT |
May. 03 | Transcript : Balchem Corporation, Q1 2024 Earnings Call, May 03, 2024 |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Over the past four months, analysts' average price target has been revised upwards significantly.
- There is high visibility into the group's activities for the coming years. Outlooks on future revenues from analysts covering the equity remain similar. Such hardly dispersed estimates support highly predictable sales for the current and upcoming fiscal years.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 40.49 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Specialty Chemicals
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.16% | 5.07B | B- | ||
+17.73% | 66.69B | A- | ||
+17.51% | 41.24B | B+ | ||
+20.17% | 25.89B | A- | ||
+12.41% | 19.81B | C+ | ||
+0.85% | 17.11B | B+ | ||
-21.87% | 15.86B | A- | ||
+3.02% | 15.35B | B+ | ||
-10.29% | 15.23B | C+ | ||
-22.30% | 13.36B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- BCPC Stock
- Ratings Balchem Corporation